Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 439 (ZNF439) is a predicted DNA-binding transcription factor active in the nucleus of human cells, primarily involved in regulating transcription by RNA polymerase II. It contains multiple C2H2-type zinc finger domains, characteristic of this large family of gene regulators. Although ZNF439 is widely expressed in diverse tissues and is included in essential gene and protein annotation resources, its specific biological and pathophysiological roles remain poorly characterized, and there is currently no data supporting its use as a drug target, disease biomarker, or subject of therapeutic modulation[1][2][3][4][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 439 (ZNF439).